有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(2-cyanophenyl)sulfanyl-N-[(1R)-1-(2-ethyl-1,3-thiazol-4-yl)ethyl]benzamide | —— | C21H19N3OS2 |
|
—— | [(3R)-2,3-dihydro-1-benzothiophen-3-yl]-[(2S)-2-(5-ethyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3O2S |
|
—— | [(3S)-2,3-dihydro-1-benzothiophen-3-yl]-[(2R)-2-(5-ethyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3O2S |
|
—— | [(3R)-2,3-dihydro-1-benzothiophen-3-yl]-[(2R)-2-(5-ethyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3O2S |
|
—— | 3-(2-bromophenyl)sulfanyl-N-[(1S)-1-(2-ethyl-1,3-thiazol-4-yl)ethyl]propanamide | —— | C16H19BrN2OS2 |
|
—— | 2-(2-cyanophenyl)sulfanyl-N-[(1S)-1-(2-ethyl-1,3-thiazol-4-yl)ethyl]benzamide | —— | C21H19N3OS2 |
|
—— | [(3S)-2,3-dihydro-1-benzothiophen-3-yl]-[(2S)-2-(5-ethyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]methanone | —— | C17H19N3O2S |
|
—— | 3-(2-bromophenyl)sulfanyl-N-[(1R)-1-(2-ethyl-1,3-thiazol-4-yl)ethyl]propanamide | —— | C16H19BrN2OS2 |
|
—— | (2R)-2-(4-methylpyrimidin-2-yl)sulfanyl-N-propylpropanamide | —— | C11H17N3OS |
|
—— | 1-[(2R)-1-methoxypropan-2-yl]-3-[(Z)-(4-methylsulfanylphenyl)methylideneamino]thiourea | —— | C13H19N3OS2 |
|
—— | (2S)-2-(4-methylpyrimidin-2-yl)sulfanyl-N-propylpropanamide | —— | C11H17N3OS |
|
—— | (3S)-4-[2-(4-bromo-2,5-dimethylphenyl)sulfanylacetyl]morpholine-3-carbonitrile | —— | C15H17BrN2O2S |
|
—— | (3R)-4-[2-(4-bromo-2,5-dimethylphenyl)sulfanylacetyl]morpholine-3-carbonitrile | —— | C15H17BrN2O2S |
|
—— | [6-(2-chlorophenyl)sulfanylpyridazin-3-yl]-[(3R)-3-methylmorpholin-4-yl]methanone | —— | C16H16ClN3O2S |
|
—— | 4-[5-[5-(4-methylpyrazol-1-yl)pentylsulfanyl]-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]morpholine | —— | C20H32N6O2S |
|
—— | (2R)-N-benzyl-2-[(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methylpropanamide | —— | C15H19N3OS3 |
|
—— | 2-ethyl-5-[(1R)-1-[1-(2-thiophen-2-ylethyl)tetrazol-5-yl]sulfanylethyl]-1,3,4-oxadiazole | —— | C13H16N6OS2 |
|
—— | (5S)-5-[[5-[(2-chloro-6-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3-oxazolidin-2-one | —— | C13H11ClFN3O3S |
|
—— | (5R)-5-[[5-[(2-chloro-6-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3-oxazolidin-2-one | —— | C13H11ClFN3O3S |
|
—— | 2-ethyl-5-[(1S)-1-[1-(2-thiophen-2-ylethyl)tetrazol-5-yl]sulfanylethyl]-1,3,4-oxadiazole | —— | C13H16N6OS2 |
|
—— | (2S)-N-benzyl-2-[(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methylpropanamide | —— | C15H19N3OS3 |
|
—— | 4-[5-[5-(4-methylpyrazol-1-yl)pentylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]morpholine | —— | C20H32N6O2S |
|
—— | (2S)-N-cyclohexyl-N-ethyl-2-[(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C15H25N3OS3 |
|
—— | [6-(2-chlorophenyl)sulfanylpyridazin-3-yl]-[(3S)-3-methylmorpholin-4-yl]methanone | —— | C16H16ClN3O2S |
|
—— | (2R)-N-cyclohexyl-N-ethyl-2-[(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C15H25N3OS3 |
|
—— | (2R)-2-(3,4-dimethylphenoxy)-N-(2-phenylsulfanylphenyl)propanamide | —— | C23H23NO2S |
|
—— | 3-{4-[(4-nitrophenyl)sulfanyl]benzyl}-1,2,3-benzotriazin-4(3H)-one | —— | C20H14N4O3S |
|
—— | (2S)-2-(3,4-dimethylphenoxy)-N-(2-phenylsulfanylphenyl)propanamide | —— | C23H23NO2S |
|
—— | 4-[[12-(4-Methoxyphenyl)sulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-10-yl]methyl]morpholin-4-ium | —— | C21H24N3O2S2+ |
|
—— | 1-[4-(4-Methoxyphenyl)sulfanyl-3-nitrophenyl]sulfonylpiperidine | —— | C18H20N2O5S2 |
|
—— | N,N-diethyl-4-(4-methoxyphenyl)sulfanyl-3-nitrobenzenesulfonamide | —— | C17H20N2O5S2 |
|
—— | 5-((4-Bromo-2-nitrophenyl)thio)-1-methyl-1h-tetrazole | —— | C8H6BrN5O2S |
|
—— | 4-[[12-(4-Methoxyphenyl)sulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-10-yl]methyl]morpholine | —— | C21H23N3O2S2 |
|
—— | N-[4-(4-Bromo-2-nitro-phenylsulfanyl)-phenyl]-acetamide | —— | C14H11BrN2O3S |
|
—— | Ethyl 4-[2-(2-nitrophenyl)sulfanylbenzoyl]piperazine-1-carboxylate | —— | C20H21N3O5S |
|
—— | 4-[[4-(4-Methoxyphenyl)sulfanyl-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl]methyl]morpholine | —— | C20H23N3O2S2 |
|
—— | (2S)-2-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]propanamide | —— | C17H22N4O2S2 |
|
—— | (2R)-2-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]propanamide | —— | C17H22N4O2S2 |
|
—— | 2-[[5-(cyclopropylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C12H18N4O2S2 |
|
—— | 2-[(3-Methylphenyl)methylsulfanyl]-5-piperidin-4-yl-1,3,4-oxadiazole | —— | C15H19N3OS |
|
—— | 2-[(3-Fluorophenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H17FN3OS+ |
|
—— | N-[5-[2-[5-(2-amino-2-oxoethyl)thiophen-2-yl]-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-N-cyclopropylpropanamide | —— | C16H18N4O3S3 |
|
—— | (2R)-N-benzyl-2-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-ethylpropanamide | —— | C21H24N4OS2 |
|
—— | (2S)-2-(2-phenylsulfanylethyl)piperidin-1-ium | —— | C13H20NS+ |
|
—— | (2S)-2-[2-(4-chlorophenyl)sulfanylethyl]piperidin-1-ium | —— | C13H19ClNS+ |
|
—— | 3-(5-Ethylsulfanyl-1,3,4-oxadiazol-2-yl)propylazanium | —— | C7H14N3OS+ |
|
—— | 2-[(2-Methylphenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C15H20N3OS+ |
|
—— | 2-[(4-Fluorophenyl)methylsulfanyl]-5-piperidin-1-ium-4-yl-1,3,4-oxadiazole | —— | C14H17FN3OS+ |
|
—— | 3-[5-[(2-Chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propylazanium | —— | C12H15ClN3OS+ |
|
—— | 3-[5-[(3-Fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]propan-1-amine | —— | C12H14FN3OS |
|